Basic Information
RNALocate ID: RLID:11004137
RNA Symbol: hsa-miR-744-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-744-5p
RNA ID: miRBase:MIMAT0004945
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24460325
Tissue/Cell Line: K562 cells
Method: Microarray
Description: Cluster analysis arranged samples and miRNAs into groups based on their expression levels, which allowed us to hypothesize the relationships between miRNAs and samples. Interestingly, 49 miRNAs were up regulated in exosomes as compared to K562 cells (Table 1), with both P-value of <= 0.05 and more than 1.5-fold changes. Data are collected from Table 1. Differentially Expressed miRNAs Between Exosomes and K562 Cells.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002696 Cytoplasm Neural progenitor cells 21363885
RLID:01002697 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002698 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002699 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002700 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11004134 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11004135 Exosome Plasma 23663360
RLID:11004136 Exosome Human mast cell line (HMC-1) 24009880
RLID:11004138 Extracellular vesicle HEK-293T cells 22849433
RLID:11004139 Microvesicle Plasma 23077538
RLID:11004140 Microvesicle Seminal plasma 23539611
RLID-D:11000216 Exosome Blood|Endothelial cells
RLID-D:11000721 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-744-5p Uterine corpus endometrial carcinoma MNDR-E-MI-68635
MNDR hsa-miR-744-5p Lymphoma MNDR-E-MI-68636
MNDR hsa-miR-744-5p Estrogen-receptor positive breast cancer MNDR-E-MI-68637
MNDR hsa-miR-744-5p Estrogen-receptor negative breast cancer MNDR-E-MI-68638
MNDR hsa-miR-744-5p Progesterone-receptor positive breast cancer MNDR-E-MI-68639
MNDR hsa-miR-744-5p Progesterone-receptor negative breast cancer MNDR-E-MI-68640
MNDR hsa-miR-744-5p Her2-receptor positive breast cancer MNDR-E-MI-68641
MNDR hsa-miR-744-5p Breast cancer luminal MNDR-E-MI-68642
MNDR hsa-miR-744-5p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-68643
MNDR hsa-miR-744-5p B cell acute lymphoblastic leukemia MNDR-E-MI-68644
MNDR hsa-miR-744-5p Gastric cancer MNDR-E-MI-68645
MNDR hsa-miR-744-5p Alzheimer disease MNDR-E-MI-68646
MNDR hsa-miR-744-5p Bladder cancer MNDR-E-MI-68647
MNDR hsa-miR-744-5p Dysautonomia familial MNDR-E-MI-68648
MNDR hsa-miR-744-5p Leukemia MNDR-E-MI-68649
MNDR hsa-miR-744-5p Cardiovascular disease MNDR-E-MI-68650
MNDR hsa-miR-744-5p Carotid stenosis MNDR-E-MI-68651
MNDR hsa-miR-744-5p Lung cancer MNDR-E-MI-68652
MNDR hsa-miR-744-5p Parkinson disease MNDR-E-MI-68653
MNDR hsa-miR-744-5p Basal-like breast cancer MNDR-E-MI-68654
MNDR hsa-miR-744-5p Pituitary neoplasms MNDR-E-MI-68655
MNDR hsa-miR-744-5p Pancreatic cancer MNDR-E-MI-68656
MNDR hsa-miR-744-5p Williams syndrome MNDR-E-MI-68657
MNDR hsa-miR-744-5p Rectum adenocarcinoma MNDR-E-MI-68658
MNDR hsa-miR-744-5p Colon cancer MNDR-E-MI-68659
MNDR hsa-miR-744-5p Colon adenocarcinoma MNDR-E-MI-68660
MNDR hsa-miR-744-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-68661
MNDR hsa-miR-744-5p Acromegaly MNDR-E-MI-68662
MNDR hsa-miR-744-5p Glioblastoma MNDR-E-MI-68663
MNDR hsa-miR-744-5p Glioma MNDR-E-MI-68664
MNDR hsa-miR-744-5p Chordoma MNDR-E-MI-68665
MNDR hsa-miR-744-5p Amyotrophic lateral sclerosis MNDR-E-MI-68666
MNDR hsa-miR-744-5p Osteosarcoma MNDR-E-MI-68667
MNDR hsa-miR-744-5p Pancreatic ductal adenocarcinoma MNDR-E-MI-68668
MNDR hsa-miR-744-5p Liver cancer MNDR-E-MI-68669
MNDR hsa-miR-744-5p Gastric adenocarcinoma MNDR-E-MI-68670
MNDR hsa-miR-744-5p Pituitary adenoma MNDR-E-MI-68671
MNDR hsa-miR-744-5p Lung adenocarcinoma MNDR-E-MI-68672
MNDR hsa-miR-744-5p Thyroid carcinoma MNDR-E-MI-68673
MNDR hsa-miR-744-5p Pancreatic adenocarcinoma MNDR-E-MI-68674
MNDR hsa-miR-744-5p Carcinoma renal cell MNDR-E-MI-68675
MNDR hsa-miR-744-5p Kidney renal papillary cell carcinoma MNDR-E-MI-68676
MNDR hsa-miR-744-5p Clear cell renal cell carcinoma MNDR-E-MI-68677
MNDR hsa-miR-744-5p Biliary tract cancer MNDR-E-MI-68678
MNDR hsa-miR-744-5p Intrahepatic cholangiocarcinoma MNDR-E-MI-68679
MNDR hsa-miR-744-5p Esophageal cancer MNDR-E-MI-68680
MNDR hsa-miR-744-5p T acute lymphoblastic leukemia MNDR-E-MI-68681
MNDR hsa-miR-744-5p Acute t cell leukemia MNDR-E-MI-68682
MNDR hsa-miR-744-5p Growth hormone-secreting pituitary adenoma MNDR-E-MI-68683
MNDR hsa-miR-744-5p Fibromyalgia MNDR-E-MI-68684
MNDR hsa-miR-744-5p Adenoma MNDR-E-MI-68685
MNDR hsa-miR-744-5p Hepatocellular carcinoma MNDR-E-MI-68686
MNDR hsa-miR-744-5p Rheumatoid arthritis MNDR-E-MI-68687
MNDR hsa-miR-744-5p Barrett's adenocarcinoma MNDR-E-MI-68688
MNDR hsa-miR-744-5p Hodgkin lymphoma MNDR-E-MI-68689
MNDR hsa-miR-744-5p Neuromyelitis optica MNDR-E-MI-68690
MNDR hsa-miR-744-5p Colorectal cancer MNDR-E-MI-68691
MNDR hsa-miR-744-5p Nasopharynx carcinoma MNDR-E-MI-68692
MNDR hsa-miR-744-5p Multiple myeloma MNDR-E-MI-68693
MNDR hsa-miR-744-5p Nasopharyngeal cancer MNDR-E-MI-68694
MNDR hsa-miR-744-5p Epstein-barr virus infections MNDR-E-MI-68695
MNDR hsa-miR-744-5p Subarachnoid hemorrhage traumatic MNDR-E-MI-68696
MNDR hsa-miR-744-5p Stroke lacunar MNDR-E-MI-68697
MNDR hsa-miR-744-5p Barrett's carcinogenesis MNDR-E-MI-68698
MNDR hsa-miR-744-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-68699
MNDR hsa-miR-744-5p Tubulovillous adenoma MNDR-E-MI-68700
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ARHGAP5 Homo sapiens RR00122473
TOP